Table: Summary of Studies of Efficacy/Effectiveness of HD-IIV3, aIIV3, and RIV4 Compared with Unadjuvanted SD-IIVs against Laboratory-Confirmed Influenza Among Older Adults*
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
An official website of the United States government
